Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study

Table 2

Clinicolaboratory parameters and US-cPD measures.

	Baseline	T4	T12	T24
ESR mean (range)	34.7 (6–79)	29.3 (5–68)	20.7 (1–76)	6.8 (2–17)
CRP mean (range)	20,8 (1.6–68.9)	18,9 (1.1–64.7)	13,1 (1.1–48.3)	5,1 (0.2–23.9)
Pain VAS mean (range)	65,0 (13–100)	50,4 (0–98)	34,4 (0–87)	12,35 (0–72)
SpA-HAQ mean (range)	1.1 (0.8–2.3)	0.5 (0.1–1)	0.1 (0–0.8)	0.0 (0–0.3)
PASI mean (range)	9.2 (0–61.8)	4.6 (0–34.5)	1.8 (0–21.2)	1.9 (0–13.9)
DAS 28-ESR mean (range)	4.6 (2.8–7.7)	4.3 (2.6–6.9)	3.7 (2.1–5.8)	2,6 (1.4–3.8)
SP mean (range)	1,125 (0–2)	0,9 (0–2)	0,15 (0-1)	0,025 (0-1)
SE mean (range)	2.3 (1–3)	1.5 (0–3)	0.4 (0–2)	0.1 (0-1)
BE mean (range)	0,2 (0–2)	0,2 (0–2)	0,2 (0–2)	0,25 (0–2)
cPD mean (range)	2.5 (1–3)	1.8 (0–3)	1.1 (0–3)	1 (0–2)